Nanotechnology in Cardiovascular Medicine: Advances in Diagnostics, Targeted Therapy, and Translational Challenges
International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-32
DOI: 10.2147/ijn.s636467 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Shuai Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Yantai Mountain Hospital, Yantai, 265400, People's Republic of China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Nanomedicine, Nanotechnology. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Yantai Mountain Hospital, Yantai, 265400, People's Republic of China.
ORCID-Profile: Xue Liu
Zitieren
APA
Li, S., Li, Q., & Liu, X. (2026). Nanotechnology in Cardiovascular Medicine: Advances in Diagnostics, Targeted Therapy, and Translational Challenges. International Journal of Nanomedicine, Volume 21, 1-32. https://doi.org/10.2147/ijn.s636467
Vancouver
Li S, Li Q, Liu X. Nanotechnology in Cardiovascular Medicine: Advances in Diagnostics, Targeted Therapy, and Translational Challenges. International Journal of Nanomedicine. 2026;Volume 21:1-32. doi:10.2147/ijn.s636467
BibTeX
@article{Li2026,
author = {Li, Shuai and Li, Qiang and Liu, Xue},
title = {Nanotechnology in Cardiovascular Medicine: Advances in Diagnostics, Targeted Therapy, and Translational Challenges},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--32},
doi = {10.2147/ijn.s636467}
}
EUVIMED